- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT06219863
Postrojová intervence mobility pro kojence s Downovým syndromem
Opatření týkající se proveditelnosti a výsledku pro kojence s Downovým syndromem: Pokročilá připravenost na klinické zkoušky pro intervence v oblasti mobility založené na postroji
The emergence of crawling and walking is significantly delayed in infants with Down syndrome (DS), but the development of independent mobility provides infants with new opportunities for exploring the environment and interacting with objects and people that are important foundations for early learning. Increasing infant mobility early in development with body weight supported harness systems may support infant exploration, communication, and social interaction. This project will set the stage for the first clinical trial of a mobility-related intervention specifically tailored for infants with DS by testing the feasibility of harness systems with infants and families and identifying measures that will serve as primary outcome variables. Upon completion of this pilot project, necessary preliminary data and experience required for an in-home, high-impact clinical trial for infants with DS will have been obtained.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
Investigators will visit families at home both in-person and virtually via Zoom. At all sessions, infants and caregivers will be videorecorded at home while playing together with the infant's own toys (15 min) and with a standard set of age-appropriate commercially available toys provided by the research team (15 min). During the harness trial period, sessions will be divided so that the infant is observed both in and out of the harness. Parent reports of language development (MacArthur-Bates Communicative Development Inventory; 10 min) and locomotor development (Locomotor Experience Interview; 10 min) will be collected at the initial visit, study midpoint (3 months), and study exit (6 months). Parents will be surveyed once about the feasibility and acceptability of the body weight supported harness system at the end of the harness trial period (10 min), and they will complete a study participation satisfaction survey at study exit (10 min). In addition, infants will be administered the Bayley Scales of Infant and Toddler Development-4 (30 min) and the Early Social Communication Scales (10 min) at the beginning, middle, and end of study participation.
Participants will be observed twice a month for 6 months (one visit per month on Zoom and the other in person), for a total of 12 observations per child.
Part 2 study participation will involve a total of 12 sessions per parent/infant dyad, lasting between 30 and 70 min, depending on the visit protocol (see above).
Each family will also have a 1-month Harness Trial Period with the PUMA system in their home. These will be staggered over the course of the study period. At the beginning of the trial period, investigators will deliver the harness system to the home and assist with setup and troubleshooting. Families will be given a brief training in harness setup and use and a safety checklist to review daily before using the system with their infant. Families will be asked to use the harness with their infant for at least 30 minutes daily. The harness will be collected by the research team at the end of the trial period. Each day during the Harness Trial Period, parents will track how long they use the harness system with their infant (in minutes), what activities they engaged in (e.g., toy play, book sharing), and any challenges they encountered (e.g., infant fussiness) in a log (5 min).
The PUMA system is an FDA registered device manufactured by Enliten LLC that provides body weight support while moving around. It consists of a 9' x 9' metal canopy frame with no cover that is adjustable in height. Infants will wear custom lightweight cloth vests designed specifically for the PUMA. The vest will be connected to a beam at the top of the structure. The PUMA supports up to 60 pounds and permits movement anywhere beneath the structure. In case of an emergency, a quick release unit can be pulled to rapidly separate the harness from the support unit. For the PUMA, this device is attached to the spreader bar, out of reach of the child user.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Anna Donato
- Telefonní číslo: (774) 275-3321
- E-mail: buicl.studies@gmail.com
Studijní místa
-
-
Massachusetts
-
Boston, Massachusetts, Spojené státy, 02215
- Nábor
- Boston University
-
Kontakt:
- Anna Donato
- Telefonní číslo: 774-275-3321
- E-mail: buicl.studies@gmail.com
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- confirmed diagnosis of Trisomy 21
- younger than 24 months
- English is the primary language of the home (due to use of standardized language assessments normed on English-speaking children)
- able to sit without support
- not yet taking any independent steps.
Exclusion Criteria:
- Mosaic or Translocation Down syndrome
- severe, uncontrolled medical problems (including heart disease with cardiovascular instability, uncontrolled epilepsy)
- severe uncorrected hearing or vision impairments
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Jiný
- Přidělení: N/A
- Intervenční model: Přiřazení jedné skupiny
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Body weight supported harness
Harness is set up in families' homes for one month. Caregivers re asked to use the harness with their infant for 30 min/day, 5 times a week. |
A body weight supported harness will be provided to families for one month to set up in their home. Caregivers will be asked to use the harness for their infants for 30 min per day, 5 days a week. Caregivers will complete a daily log describing harness use. At the end of the month, they will complete feasibility and acceptability questionnaires. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Mean posture duration in seconds
Časové okno: 6 months
|
Average time spent in supine, prone, sitting, standing |
6 months
|
|
Mean number of locomotion bouts
Časové okno: 6 months
|
Mean instances of crawling, cruising, walking, or other forms of locomotion |
6 months
|
|
Mean time spent in contact with objects
Časové okno: 6 months
|
Average time infants spend touching objects |
6 months
|
|
Mean number of different objects contacted
Časové okno: 6 months
|
Average number of unique objects touched |
6 months
|
|
Mean number of vocalizations
Časové okno: 6 months
|
Average number of speech-like sound productions |
6 months
|
|
Mean number of gestures
Časové okno: 6 months
|
Average number of gestures |
6 months
|
|
Proportion of directed vocalizations
Časové okno: 6 months
|
Proportion of total vocalizations accompanied by looking to the caregiver |
6 months
|
|
Proportion of directed gestures
Časové okno: 6 months
|
Proportion of total gestures accompanied by looking to the caregiver |
6 months
|
|
Bayley Scales of Infant Development-4
Časové okno: Study entry, 3 months, 6 months
|
Comprehensive, standardized measure of general development for children from 1-42 months, with five subscales: Cognitive, Language, Motor, Social-Emotional, and Adaptive Behavior. Raw scores will be used. Minimum score is 0; there is no maximum score. Higher scores indicate a better outcome. |
Study entry, 3 months, 6 months
|
|
Early Social Communication Scales
Časové okno: Study entry, 3 months, 6 months
|
Structured experimenter-administered observation of nonverbal communication skills: assesses joint attention, requesting, and social interaction skills. Minimum score is 0. There is no maximum score. Higher scores mean a better outcome. |
Study entry, 3 months, 6 months
|
|
MacArthur-Bates Communication Development Inventory: Words & Gestures
Časové okno: Study entry, 3 months, 6 months
|
Parent questionnaire identifying words that the child only understands and those that s/he both says and understands as well as production of early gestures (e.g., showing, pointing) and actions (e.g., games, routines). There are seven subscales. Raw scores will be reported for each one, and all have a minimum score of 0. Higher scores mean better outcomes. Words Understood (maximum score = 396) Words Produced (maximum score = 396) First Communicative Gestures (maximum score = 12) Games and Routines (maximum score = 6) Actions with Objects (maximum score = 17) Pretending to be a Parent (maximum score = 13) Imitating Other Adult Actions (maximum score = 15) |
Study entry, 3 months, 6 months
|
Spolupracovníci a vyšetřovatelé
Spolupracovníci
Vyšetřovatelé
- Vrchní vyšetřovatel: Jana Iverson, PhD, Boston University
- Vrchní vyšetřovatel: Nicole Baumer, MD, Boston Children's Hospital
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 6930E
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Data from standardized assessments will be shared with the NIH INCLUDE database.
Časový rámec sdílení IPD
One year after study completion
Kritéria přístupu pro sdílení IPD
Access granted to approved users of the INCLUDE database
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .